Cory Dunnick, MD
Dermatology · Aurora, CONPI 1720171176
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $27,351 of the $39,275 with a category attached, or 69.6%. Pfizer accounts for 93.3% of it on its own, with 17 other manufacturers making up the rest. Among dermatology clinicians in CO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 121 payments — averaging $324.58 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$37K
- LEO Pharma Inc.$693
- AbbVie$331
- Regeneron Healthcare Solutions, Inc.$278
- UCB, Inc.$220
- E.r. Squibb & Sons, L.L.C.$174
- plus $918 from 12 others
Across 75 payments — averaging $4360.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$272K
- Amgen$31K
- AbbVie$18K
- Regeneron$5K
- Bristol Myers Squibb$250
- Novartis$220
What the payments were for
- Consulting fees$7,69520%
- Speaking & faculty fees$27,35170%
- Travel & lodging$5881%
- Food & beverage$3,6419%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 35 | $36,661 |
| LEO Pharma Inc. | 15 | $693 |
| AbbVie(2 entities) | 11 | $331 |
| Regeneron Healthcare Solutions, Inc. | 10 | $278 |
| UCB, Inc. | 7 | $220 |
| E.r. Squibb & Sons, L.L.C. | 3 | $174 |
| Journey Medical Corporation | 2 | $157 |
| Incyte Corporation | 8 | $143 |
| Sanofi | 6 | $143 |
| Lilly USA, LLC | 4 | $113 |
| Johnson & Johnson | 4 | $111 |
| Novartis | 4 | $84 |
| Galderma Laboratories, L.p. | 4 | $71 |
| Organon | 4 | $23 |
| Amgen | 1 | $19 |
| Botanix SB Inc | 1 | $19 |
| Almirall LLC | 1 | $18 |
| Dermavant Sciences, Inc. | 1 | $18 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$39,275 in reported general payments places this provider in the 90th percentile of 280 dermatology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 31 | $1,243 |
| Ciclopirox | 22 | $912 |
| Ketoconazole | 37 | $770 |
| Clindamycin Phosphate | 12 | $465 |
| Triamcinolone Acetonide | 40 | $253 |
| Minoxidil | 19 | $199 |
| Doxycycline Hyclate | 12 | $184 |
| Hydrocortisone | 16 | $160 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Aurora
- David NorrisAurora$156K
- Dawnielle EndlyAurora$105K
- Torunn SivesindAurora$93K
- Carla Torres-ZegarraAurora$62K
- Theodore AlkousakisAurora$34K
- Emily GorellAurora$27K
- Ryan GambleAurora$10K
- Jennifer RayAurora$9K
- Ryan OlearyAurora$8K
- Marcjonathan SerotaLittleton$3.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.